Frequently bundled, frequently confused. Two different molecules described as acting on different receptors.
These two are bundled together often enough that people assume they are variants of one compound. They are not. They are different molecules described as acting through different pathways.
A synthetic analog of growth hormone releasing hormone (GHRH). The "with DAC" designation refers to a Drug Affinity Complex, a modification that binds the molecule to albumin in circulation, which substantially extends its half-life compared with the unmodified peptide.
A growth hormone secretagogue described in the literature as a selective agonist at the ghrelin receptor. It is a pentapeptide, structurally unrelated to GHRH.
| CJC-1295 w/ DAC | Ipamorelin | |
|---|---|---|
| Molecular class | GHRH analog | Growth hormone secretagogue |
| Described target | GHRH receptor | Ghrelin receptor |
| Structure | Modified GHRH sequence | Pentapeptide |
| Half-life note | Extended by DAC modification | Short, unmodified |
| Vial size | 10mg | 10mg |
| Price | $150 | $100 |
Because they are described as acting on different receptors within the same signalling system. That is why the research literature frequently examines them in combination, and why we bundle them in the Growth Hormone Stack.
Bundling is a pricing and convenience decision. The vials arrive separately and are reconstituted separately. See what is in each stack.
Product pages: CJC-1295 w/ DAC · Ipamorelin · Growth Hormone Stack
Message the team on Telegram and we will sort it out, usually within minutes.
Message the team on Telegram10mg vials, or the Growth Hormone Stack at bundle pricing.